$DARA Headlines Dara chemo side-effect drug ge
Post# of 102773
Posted On: 07/11/2014 10:42:15 AM
$DARA Headlines
Dara chemo side-effect drug gets 'orphan status' 10:16 a.m. Feb. 25, 2014 - MarketWatch.com
Wednesday’s biggest gaining and declining stocks 5:46 p.m. Dec. 29, 2010 - Kate Gibson
DARA Snags Second Orphan Indication For KRN5500 10:48 p.m. June 17, 2014 - Seeking Alpha
Dara compound named an orphan drug for myeloma 11:34 a.m. June 16, 2014 - Seeking Alpha
Why DARA BioSciences (DARA) Stock is Surging Today 10:55 a.m. June 16, 2014 - TheStreet.com
Why DARA Biosciences (DARA) Stock Is Plunging Today 10:30 a.m. May 30, 2014 - TheStreet.com
DARA Biosciences (DARA) Stock Plunges After Wednesday Surge 12:14 p.m. May 29, 2014 - TheStreet.com
Dara Biosciences (DARA) Stock Explodes Today (Update) 4:08 p.m. May 28, 2014 - TheStreet.com
Dara up big 1:45 p.m. May 28, 2014 - Seeking Alpha
DARA Bio - Waiting For Progress 11:55 a.m. May 14, 2014 - Seeking Alpha
10-Q: DARA BIOSCIENCES, INC. 4:27 p.m. May 12, 2014 - Edgar Online - (EDG = 10Q, 10K)
CAPTURE Data Should Help Drive Soltamox Sales At DARA Bio 9:08 a.m. March 15, 2014 - Seeking Alpha
Tamoxifen tablet survey a mixed bag for Dara 8:54 a.m. March 13, 2014 - Seeking Alpha
More on DARA Bioscience 9:53 a.m. March 5, 2014 - Seeking Alpha
DARA up 10% premarket on Soltamox entry at Wellcare 9:53 a.m. March 5, 2014 - Seeking Alpha
SA PRO: Top Long And Short Ideas, Thursday February 27 8:30 a.m. Feb. 28, 2014 - Seeking Alpha
DARA: Next Steps After Awarding Of Orphan Designation For KRN5500 9:52 a.m. Feb. 27, 2014 - Seeking Alpha
Still Betting On DARA Bio 10:00 a.m. Feb. 11, 2014 - Seeking Alpha
10-K: DARA BIOSCIENCES, INC. 8:03 a.m. Feb. 4, 2014 - Edgar Online - (EDG = 10Q, 10K)
Notes From One-On-One Meetings During San Fran Biotech Week - Day 2 10:05 a.m. Jan. 23, 2014 - Seeking Alpha
Orphan Designation A Game-Changer For DARA 11:00 a.m. Dec. 16, 2013 - Seeking Alpha
10-Q: DARA BIOSCIENCES, INC. 5:36 p.m. Nov. 13, 2013 - Edgar Online - (EDG = 10Q, 10K)
Agreements, Orphan Drug Designations, and Management Changes - Analyst Notes on Medtronic, DARA BioSciences, Sequenom, AcelRx and Pernix 5:20 a.m. June 19, 2014 - PR Newswire - PRF
DARA BioSciences Announces Leadership Transition 2:35 a.m. June 18, 2014 - Marketwire
DARA BioSciences' KRN5500 Granted Orphan Drug Designation by FDA for Treatment of Multiple Myeloma 7:01 a.m. June 16, 2014 - Marketwire
DARA BioSciences Launches Oral Mucositis Care App to Provide Cancer Patients with an Educational Resource to Improve Side Effect Management 8:02 a.m. June 3, 2014 - BusinessWire - BZX
Active Equities to Watch -- Research on CSX Corp., Gerdau, Walter Energy, and DARA BioSciences 8:00 a.m. June 2, 2014 - PR Newswire - PRF
DARA BioSciences, Inc. Announces Pricing of $12.5 Million Public Offering 8:48 a.m. May 30, 2014 - Marketwire
DARA BioSciences Observes National Neuropathy Awareness Week 8:32 a.m. May 15, 2014 - Marketwire
DARA BioSciences Announces First Quarter 2014 Results 4:11 p.m. May 12, 2014 - Marketwire
DARA BioSciences Announces New Retail Patient Savings Program to Support Market Demand for DARA's Flagship Oncology Products 8:31 a.m. May 9, 2014 - Marketwire
DARA BioSciences Announces Addition of Soltamox(R), (Tamoxifen Citrate) Oral Solution, to the Authorized Federal Supply Schedule Price List 8:04 a.m. May 8, 2014 - Marketwire
DARA BioSciences Announces Date and Time for Announcement of First Quarter 2014 Results 1:14 p.m. April 30, 2014 - Marketwire
Dara BioSciences to Present at the 12th Annual eyeforpharma Philadelphia 2014 Summit 8:06 a.m. April 14, 2014 - Marketwire
DARA BioSciences Presents Results of Breast Cancer CAPTURE Registry at NCCN® 19th Annual Conference: Advancing the Standard of Cancer Care™ 8:01 a.m. March 13, 2014 - BusinessWire - BZX
DARA BioSciences to Present at 26th Annual ROTH Conference 9:06 a.m. March 6, 2014 - Marketwire
DARA BioSciences Signs Medicare Part D Prescription Drug Agreement With the WellCare(R) Group, Providing Approved Formulary Status for Soltamox(R) 9:06 a.m. March 5, 2014 - Marketwire
DARA BioSciences Observes Rare Disease Day 9:36 a.m. Feb. 27, 2014 - Marketwire
DARA BioSciences Regains Compliance With NASDAQ Bid Price Requirement 5:02 p.m. Feb. 25, 2014 - Marketwire
DARA BioSciences' KRN5500 Receives Orphan Drug Designation From FDA 9:06 a.m. Feb. 25, 2014 - Marketwire
DARA BioSciences Announces Registered Direct Offering of $6.0 Million 9:31 a.m. Feb. 12, 2014 - Marketwire
DARA BioSciences Announces 1-for-5 Reverse Split 9:02 a.m. Feb. 6, 2014 - Marketwire
Dara chemo side-effect drug gets 'orphan status' 10:16 a.m. Feb. 25, 2014 - MarketWatch.com
Wednesday’s biggest gaining and declining stocks 5:46 p.m. Dec. 29, 2010 - Kate Gibson
DARA Snags Second Orphan Indication For KRN5500 10:48 p.m. June 17, 2014 - Seeking Alpha
Dara compound named an orphan drug for myeloma 11:34 a.m. June 16, 2014 - Seeking Alpha
Why DARA BioSciences (DARA) Stock is Surging Today 10:55 a.m. June 16, 2014 - TheStreet.com
Why DARA Biosciences (DARA) Stock Is Plunging Today 10:30 a.m. May 30, 2014 - TheStreet.com
DARA Biosciences (DARA) Stock Plunges After Wednesday Surge 12:14 p.m. May 29, 2014 - TheStreet.com
Dara Biosciences (DARA) Stock Explodes Today (Update) 4:08 p.m. May 28, 2014 - TheStreet.com
Dara up big 1:45 p.m. May 28, 2014 - Seeking Alpha
DARA Bio - Waiting For Progress 11:55 a.m. May 14, 2014 - Seeking Alpha
10-Q: DARA BIOSCIENCES, INC. 4:27 p.m. May 12, 2014 - Edgar Online - (EDG = 10Q, 10K)
CAPTURE Data Should Help Drive Soltamox Sales At DARA Bio 9:08 a.m. March 15, 2014 - Seeking Alpha
Tamoxifen tablet survey a mixed bag for Dara 8:54 a.m. March 13, 2014 - Seeking Alpha
More on DARA Bioscience 9:53 a.m. March 5, 2014 - Seeking Alpha
DARA up 10% premarket on Soltamox entry at Wellcare 9:53 a.m. March 5, 2014 - Seeking Alpha
SA PRO: Top Long And Short Ideas, Thursday February 27 8:30 a.m. Feb. 28, 2014 - Seeking Alpha
DARA: Next Steps After Awarding Of Orphan Designation For KRN5500 9:52 a.m. Feb. 27, 2014 - Seeking Alpha
Still Betting On DARA Bio 10:00 a.m. Feb. 11, 2014 - Seeking Alpha
10-K: DARA BIOSCIENCES, INC. 8:03 a.m. Feb. 4, 2014 - Edgar Online - (EDG = 10Q, 10K)
Notes From One-On-One Meetings During San Fran Biotech Week - Day 2 10:05 a.m. Jan. 23, 2014 - Seeking Alpha
Orphan Designation A Game-Changer For DARA 11:00 a.m. Dec. 16, 2013 - Seeking Alpha
10-Q: DARA BIOSCIENCES, INC. 5:36 p.m. Nov. 13, 2013 - Edgar Online - (EDG = 10Q, 10K)
Agreements, Orphan Drug Designations, and Management Changes - Analyst Notes on Medtronic, DARA BioSciences, Sequenom, AcelRx and Pernix 5:20 a.m. June 19, 2014 - PR Newswire - PRF
DARA BioSciences Announces Leadership Transition 2:35 a.m. June 18, 2014 - Marketwire
DARA BioSciences' KRN5500 Granted Orphan Drug Designation by FDA for Treatment of Multiple Myeloma 7:01 a.m. June 16, 2014 - Marketwire
DARA BioSciences Launches Oral Mucositis Care App to Provide Cancer Patients with an Educational Resource to Improve Side Effect Management 8:02 a.m. June 3, 2014 - BusinessWire - BZX
Active Equities to Watch -- Research on CSX Corp., Gerdau, Walter Energy, and DARA BioSciences 8:00 a.m. June 2, 2014 - PR Newswire - PRF
DARA BioSciences, Inc. Announces Pricing of $12.5 Million Public Offering 8:48 a.m. May 30, 2014 - Marketwire
DARA BioSciences Observes National Neuropathy Awareness Week 8:32 a.m. May 15, 2014 - Marketwire
DARA BioSciences Announces First Quarter 2014 Results 4:11 p.m. May 12, 2014 - Marketwire
DARA BioSciences Announces New Retail Patient Savings Program to Support Market Demand for DARA's Flagship Oncology Products 8:31 a.m. May 9, 2014 - Marketwire
DARA BioSciences Announces Addition of Soltamox(R), (Tamoxifen Citrate) Oral Solution, to the Authorized Federal Supply Schedule Price List 8:04 a.m. May 8, 2014 - Marketwire
DARA BioSciences Announces Date and Time for Announcement of First Quarter 2014 Results 1:14 p.m. April 30, 2014 - Marketwire
Dara BioSciences to Present at the 12th Annual eyeforpharma Philadelphia 2014 Summit 8:06 a.m. April 14, 2014 - Marketwire
DARA BioSciences Presents Results of Breast Cancer CAPTURE Registry at NCCN® 19th Annual Conference: Advancing the Standard of Cancer Care™ 8:01 a.m. March 13, 2014 - BusinessWire - BZX
DARA BioSciences to Present at 26th Annual ROTH Conference 9:06 a.m. March 6, 2014 - Marketwire
DARA BioSciences Signs Medicare Part D Prescription Drug Agreement With the WellCare(R) Group, Providing Approved Formulary Status for Soltamox(R) 9:06 a.m. March 5, 2014 - Marketwire
DARA BioSciences Observes Rare Disease Day 9:36 a.m. Feb. 27, 2014 - Marketwire
DARA BioSciences Regains Compliance With NASDAQ Bid Price Requirement 5:02 p.m. Feb. 25, 2014 - Marketwire
DARA BioSciences' KRN5500 Receives Orphan Drug Designation From FDA 9:06 a.m. Feb. 25, 2014 - Marketwire
DARA BioSciences Announces Registered Direct Offering of $6.0 Million 9:31 a.m. Feb. 12, 2014 - Marketwire
DARA BioSciences Announces 1-for-5 Reverse Split 9:02 a.m. Feb. 6, 2014 - Marketwire
(0)
(0)